Lifesaving new drug offers hope to 7,000 Britons a year who suffer a dangerous ... trends now
View
comments
Thousands of people with a potentially deadly heart condition are set to benefit after NHS bosses sanctioned use of a groundbreaking new drug.
Mavacamten – also known as Camzyos – is the first medicine developed specifically to tackle obstructive hypertrophic cardiomyopathy, a serious disorder that affects about 7,000 people in the UK.
It causes heart muscle to thicken and become stiff – making it harder for it to pump oxygen-rich blood round the body. Symptoms include severe fatigue, dizziness, shortness of breath, chest pain and palpitations.
About 50 per cent of cases are genetic and there is a high risk of heart failure, stroke and even sudden death from the heart stopping completely.
Doctors
